detalle del documento
IDENTIFICACIÓN
oai:pubmedcentral.nih.gov:7480...
Tema
ArticleAutor
Yang, Juan Chen, Xinhua Deng, Xiaowei Chen, Zhiyuan Gong, Hui Yan, Han Wu, Qianhui Shi, Huilin Lai, Shengjie Ajelli, Marco Viboud, Cecile Yu, HongjieLangue
enEditor
Cold Spring Harbor Laboratory
Categoría
medrxiv
Año
2020
fecha de cotización
16/8/2021
Palabras clave
severity influenza disease burden clinical pandemic covid-19Resumen
The pandemic of novel coronavirus disease 2019 (COVID-19) began in Wuhan, China, where a first wave of intense community transmission was cut short by interventions.
Using multiple data source, we estimated the disease burden and clinical severity of COVID-19 by age in Wuhan from December 1, 2019 to March 31, 2020.
We adjusted estimates for sensitivity of laboratory assays and accounted for prospective community screenings and healthcare seeking behaviors.
Rates of symptomatic cases, medical consultations, hospitalizations and deaths were estimated at 796 (95%CI: 703–977), 489 (472–509), 370 (358–384), and 36.2 (35.0–37.3) per 100,000 persons, respectively.
The COVID-19 outbreak in Wuhan had higher burden than the 2009 influenza pandemic or seasonal influenza, and that clinical severity was similar to that of the 1918 influenza pandemic.
Our comparison puts the COVID-19 pandemic into context and could be helpful to guide intervention strategies and preparedness for the potential resurgence of COVID-19.
Yang, Juan,Chen, Xinhua,Deng, Xiaowei,Chen, Zhiyuan,Gong, Hui,Yan, Han,Wu, Qianhui,Shi, Huilin,Lai, Shengjie,Ajelli, Marco,Viboud, Cecile,Yu, Hongjie, 2020, Disease burden and clinical severity of the first pandemic wave of COVID-19 in Wuhan, China, Cold Spring Harbor Laboratory
Investigating Facilitatory Effects of Lithium on Methamphetamine-induced Spatial Memory Impairments in Rat
apoptosis edema treatment ma effects brain rats
